| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Byungchul Yu, Ji Yeon Lee, Yong Beom Kim, Hee Yeon Park, Junsu Jung, Youn Yi J. Management of a trauma patient with alcohol withdrawal who developed neuroleptic malignant syndrome in Korea: a case report. Journal of trauma and injury. vol 36. issue 3. 2024-10-09. PMID:39381710. |
he was suspected nms with abrupt increase body temperature to 41.7°c after haloperidol administration. |
2024-10-09 |
2024-10-11 |
Not clear |
| Koumi Miyasaka, Sakiko Hirofuji, Mika Maezawa, Satoshi Nakao, Moe Yamashita, Nanaka Ichihara, Yuka Nokura, Hirofumi Tamaki, Kazuhiro Iguchi, Mitsuhiro Nakamur. Evaluation of Antipsychotic-Induced Neuroleptic Malignant Syndrome Using a Self-Organizing Map. Cureus. vol 16. issue 8. 2024-10-01. PMID:39350836. |
the numbers of cases of nms (smq code: 20000044) reported for risperidone, aripiprazole, haloperidol, olanzapine, and quetiapine were 1691, 1294, 1132, 1056, and 986, respectively. |
2024-10-01 |
2024-10-03 |
Not clear |
| Nicole Kraaijvanger, Tim Mielo. Neuroleptic malignant syndrome after overdose of haloperidol - A case report. Toxicology reports. vol 12. 2024-04-01. PMID:38560509. |
this case report delineates a case where nms was precipitated by an excessive intake of haloperidol, a typical antipsychotic drug. |
2024-04-01 |
2024-04-04 |
Not clear |
| Sakiko Hirofuji, Koumi Miyasaka, Mika Maezawa, Wataru Wakabayashi, Keita Oura, Satoshi Nakao, Nanaka Ichihara, Yuka Nokura, Moe Yamashita, Kensuke Matsui, Hideyuki Tanaka, Mayuko Masuta, Ichiro Ieiri, Kazuhiro Iguchi, Mitsuhiro Nakamur. Evaluation of neuroleptic malignant syndrome induced by antipsychotic drugs using spontaneous reporting system. Heliyon. vol 9. issue 11. 2023-11-30. PMID:38034668. |
rors (95 % confidence interval) of nms for haloperidol, chlorpromazine, risperidone, and aripiprazole were 12.1 (11.1-13.3), 6.3 (5.7-7.0), 6.2 (5.8-6.6), and 4.7 (4.4-5.1), respectively. |
2023-11-30 |
2023-12-10 |
Not clear |
| Brianna Cocuzzo, Kristy A Fisher, Clara L Alvarez Villalb. Neuroleptic Malignant Syndrome Status Post Anoxic Brain Injury: A Case Presentation of Heightened Susceptibility in the Brain Injury Population. Cureus. vol 15. issue 3. 2023-04-07. PMID:37025743. |
to the best of our knowledge, this will be the first documented case of a critically ill patient, with a history of prior exposure to antipsychotics, who suffered an anoxic brain injury with subsequent development of nms after the initiation of haloperidol for the treatment of acute agitation. |
2023-04-07 |
2023-08-14 |
Not clear |
| Chi-Ju Yang, Ching-Tang Chiu, Yu-Chang Yeh, Anne Cha. Successful management of delirium with dexmedetomidine in a patient with haloperidol-induced neuroleptic malignant syndrome: A case report. World journal of clinical cases. vol 10. issue 2. 2022-01-31. PMID:35097088. |
we report a case of lorazepam-induced agitated delirium treated with haloperidol, which in turn triggered the onset of neuroleptic malignant syndrome (nms). |
2022-01-31 |
2023-08-13 |
Not clear |
| Lara Youniss, Michele Thomas, Erica A K Davi. Probable haloperidol decanoate-induced fever in an African American with benign ethnic neutropenia: A case report. The mental health clinician. vol 11. issue 5. 2021-10-09. PMID:34621607. |
we present a case in which a patient developed fever and leukocytosis subsequent to each monthly haloperidol decanoate injection, an adverse reaction that does not meet the diagnostic criteria of neuroleptic malignant syndrome (nms) or any previously reported adverse reaction for this medication. |
2021-10-09 |
2023-08-13 |
Not clear |
| Po-Hao Chen, Hsien-Yuan Lane, Chieh-Hsin Li. Venous Thromboembolism Following Dantrolene Treatment for Neuroleptic Malignant Syndrome. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 14. issue 4. 2020-09-30. PMID:27776396. |
here we report a young male patient with bipolar i disorder who developed nms after rapid tranquilization with haloperidol. |
2020-09-30 |
2023-08-13 |
Not clear |
| N Wystub, S Heymel, M Fritzenwanger, P C Schulze, R Pfeife. [Prolonged neuroleptic malignant syndrome after Haloperidol injection]. Medizinische Klinik, Intensivmedizin und Notfallmedizin. vol 113. issue 3. 2019-05-30. PMID:28752347. |
therapy in nms includes withdrawal of the causative medication and intensive care treatment possibly with administration of dantrolene.in this case report, we describe the clinical course of a 48 year old man who developed typical clinical symptoms and laboratory parameters of malignant hyperthermia syndrome after injection of haloperidol. |
2019-05-30 |
2023-08-13 |
Not clear |
| Agnieszka Butwicka, Szymańska Krystyna, Włodzimierz Retka, Tomasz Wolańczy. Neuroleptic malignant syndrome in an adolescent with CYP2D6 deficiency. European journal of pediatrics. vol 173. issue 12. 2015-07-21. PMID:24253372. |
following continuous treatment with olanzapine (10 mg/day), repeated injections of levomepromazine (37.5 mg/day), and a single injection of haloperidol (2.5 mg), the patient developed nms. |
2015-07-21 |
2023-08-12 |
Not clear |
| Donghua Zou, Yu Shao, Zhiqiang Qin, Jianhua Zhang, Ningguo Liu, Zhengdong Li, Ping Huang, Yijiu Che. Death due to fulminant neuroleptic malignant syndrome induced by low doses of haloperidol: a rare case. Journal of forensic and legal medicine. vol 24. 2015-01-05. PMID:24794843. |
the paper reports on a rare case of fulminant neuroleptic malignant syndrome (nms) with several risk factors, typical manifestation and rapid death induced by low doses of haloperidol. |
2015-01-05 |
2023-08-13 |
Not clear |
| Bhawna Sharma, Raghavendra Bakki Sannegowda, Pankaj Gandhi, Parul Dubey, Ashok Panagariy. Combination of Steven-Johnson syndrome and neuroleptic malignant syndrome following carbamazepine therapy: a rare occurrence. BMJ case reports. vol 2013. 2014-09-16. PMID:23761563. |
among the neuroleptics, haloperidol (parenteral) is implicated as a most common drug for nms. |
2014-09-16 |
2023-08-12 |
Not clear |
| Leticia González-Blanco, Hilario García-Prada, Susana Santamarina, Luis Jiménez-Treviño, Julio Bobe. Recurrence of neuroleptic malignant syndrome. Actas espanolas de psiquiatria. vol 41. issue 5. 2014-09-04. PMID:24096397. |
we present that case of an 81-year old woman who was admitted to the psychiatric hospitalization unit (phu) for a depressive episode with psychotic symptoms who developed a neuroleptic malignant syndrome (nms) when haloperidol was introduced. |
2014-09-04 |
2023-08-12 |
Not clear |
| Praveen Tripathi, Hemika Agrawal, Priyanka Goyal, Sujita Kumar Ka. Olanzapine-induced neuroleptic malignant syndrome in a patient with bipolar affective disorder: Does quetiapine holds the solution? Industrial psychiatry journal. vol 22. issue 2. 2014-07-11. PMID:25013321. |
in this case report- we highlight the management issues of a patient suffering from bipolar affective disorder, who had developed nms following intramuscular injection of haloperidol, which was withdrawn and olanzapine was given later on. |
2014-07-11 |
2023-08-13 |
Not clear |
| Zexiang Ouyang, Li Ch. A case of recurrent neuroleptic malignant syndrome. Shanghai archives of psychiatry. vol 25. issue 4. 2014-07-03. PMID:24991164. |
nms occurred after combined treatment with haloperidol and aripiprazole (the first episode) and, four years later, after combined treatment with haloperidol and clozapine (the second episode). |
2014-07-03 |
2023-08-13 |
Not clear |
| Deepali Dixit, Pranabh Shrestha, Marc Adelma. Neuroleptic malignant syndrome associated with haloperidol use in critical care setting: should haloperidol still be considered the drug of choice for the management of delirium in the critical care setting? BMJ case reports. vol 2013. 2014-03-10. PMID:23853022. |
neuroleptic malignant syndrome (nms) associated with haloperidol was suspected. |
2014-03-10 |
2023-08-12 |
Not clear |
| Deepali Dixit, Pranabh Shrestha, Marc Adelma. Neuroleptic malignant syndrome associated with haloperidol use in critical care setting: should haloperidol still be considered the drug of choice for the management of delirium in the critical care setting? BMJ case reports. vol 2013. 2014-03-10. PMID:23853022. |
the temporal relationship between the patient's fever decline with the discontinuation of haloperidol, and improvement with dantrolene and bromocriptine, the diagnosis was believed to be haloperidol-induced nms. |
2014-03-10 |
2023-08-12 |
Not clear |
| M Azhar, S Varm. Electro-convulsive therapy in neuroleptic malignant syndrome. European psychiatry : the journal of the Association of European Psychiatrists. vol 10. issue 2. 2012-10-02. PMID:19698324. |
a middle aged lady having manic-depressive psychosis developed neuroleptic malignant syndrome (nms) on haloperidol. |
2012-10-02 |
2023-08-12 |
Not clear |
| Naseem A Quresh. Neuroleptic malignant syndrome. Diagnostic and therapeutic dilemmas in a general hospital setting. Neurosciences (Riyadh, Saudi Arabia). vol 13. issue 4. 2012-10-02. PMID:21063378. |
after 3 days, she suddenly developed signs and symptoms of nms possibly caused by prn injectable haloperidol, although the additional role of olanzapine could not be ruled out. |
2012-10-02 |
2023-08-12 |
Not clear |
| J P Alexander, R M Thomas, A Da. Occurrence of neurolepric malignant syndrome on trihexphenidyl discontinuation. Indian journal of psychiatry. vol 38. issue 4. 2011-07-14. PMID:21584140. |
we report a case of nms, which occurred in a patient on lithium, haloperidol and trihexyphenidyl (thp) after sudden discontinuation of thp. |
2011-07-14 |
2023-08-12 |
Not clear |